ad image

Pain Therapeutics

1 / 1
The Next Frontier in Neurological Diagnostics and Therapeutics
Neurology

The Next Frontier in Neurological Diagnostics and Therapeutics

Dave Rosa

NeuroOne

PAO-05-24-CL-02May 30, 2024
Unlocking the Therapeutic Potential of Plant-Inspired Minimum Essential Mixtures
Plant-Inspired Drug Discovery

Unlocking the Therapeutic Potential of Plant-Inspired Minimum Essential Mixtures

Andrea Small-Howard, Ph.D.

Gb Sciences, Inc.

PAO-08-022-CL-01Sep 06, 2022
Late-Stage Positive Results Reported for Nerve Growth Factor Inhibitor
Clinical Trials

Late-Stage Positive Results Reported for Nerve Growth Factor Inhibitor

Nice Insight

PAO-M02-19-NI-017Feb 21, 2019
Teva Pharmaceutical Industries
Study Results

Teva and Regeneron Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip

Teva Pharmaceutical Industries

PR-M09-18-NI-051Sep 18, 2018
DURECT Corporation
FDA

DURECT's Licensee Pain Therapeutics Receives Complete Response Letter from FDA for REMOXY® ER (oxycodone) Extended-Release Capsules CII

DURECT Corporation

PR-M08-18-NI-059Aug 15, 2018
1 / 1